Buprenorphine Product Switch for Opioid Use Disorder (FDA Labels)
The corresponding dose when a patient with opioid use disorder moves between buprenorphine products, by each label's table.
Open the tool → Runs in your browser. Data leaves only if you deliberately send a problem report from the interactive tool.
Example
- From which product to which
- Sublingual buprenorphine to Brixadi
- Current dose
- 16 mg
Result: Brixadi weekly 24 mg, or Brixadi monthly 96 mg.
The tool opens with these values already filled in. Replace them with your own.
What you enter
- From which product to which
- Current dose: mg of buprenorphine a day (or the Brixadi weekly or monthly dose)
- Date of the first injection (YYYY-MM-DD, optional)
How this is calculated
Citation
FDA labels on DailyMed: Zubsolv 2.9 (corresponding Suboxone tablet strengths), Brixadi 2.3 (Tables 1 and 2: sublingual buprenorphine to weekly or monthly, and weekly to monthly) and Sublocade 2.3 (transition from transmucosal buprenorphine). Read the sources: Zubsolv label ↗, Brixadi label ↗, Sublocade label ↗
A reference and educational tool. Not medical, legal, or financial advice, and not a substitute for clinician judgment.